Home › StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio
 

Keywords :   


StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio

2013-10-30 05:24:33| drugdiscoveryonline News Articles

StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents to which it had previously held an exclusive worldwide license

Tags: cell portfolio stem patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
More »